|
End-of-day quote
Ho Chi Minh S.E.
2026-09-17
|
5-day change | 1st Jan Change | ||
| 90,000.00 VND | -0.11% |
|
-5.96% | -12.02% |
Company Valuation: DHG Pharmaceutical
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 14,774,306 | 11,100,341 | 13,597,591 | 13,584,517 | 13,375,323 | 11,767,146 | - | - |
| Change | - | -24.87% | 22.5% | -0.1% | -1.54% | -12.02% | - | - |
| Enterprise Value (EV) 1 | 12,828,324 | 11,100,341 | 11,845,622 | 11,426,573 | 11,221,427 | 9,904,646 | 9,909,346 | 9,916,346 |
| Change | - | -13.47% | 6.71% | -3.54% | -1.8% | -11.73% | 0.05% | 0.07% |
| P/E | 19.8x | 11.6x | 13.4x | 18x | 15.4x | 12.7x | 12x | 11.2x |
| PBR | 3.9x | 2.59x | - | - | - | - | - | - |
| PEG | - | 0.4x | 2.1x | -0.7x | 1x | 1.85x | 2.02x | 1.7x |
| Capitalization / Revenue | 3.69x | 2.37x | 2.71x | 2.78x | 2.54x | 2.17x | 2.07x | 1.97x |
| EV / Revenue | 3.2x | 2.37x | 2.36x | 2.34x | 2.13x | 1.82x | 1.74x | 1.66x |
| EV / EBITDA | 13.6x | 9.59x | 10.4x | 10.5x | 10.2x | 8.57x | 7.93x | 7.42x |
| EV / EBIT | 14.5x | 9.98x | 11.2x | 12.4x | 11.4x | 9.45x | 8.71x | 8.13x |
| EV / FCF | 30x | 16.6x | -48.1x | 9.3x | 9.48x | 20.3x | 12.2x | 11.7x |
| FCF Yield | 3.34% | 6.01% | -2.08% | 10.8% | 10.5% | 4.93% | 8.21% | 8.54% |
| Dividend per Share 2 | 4,000 | - | - | 10,000 | - | 7,000 | 7,200 | 7,500 |
| Rate of return | 3.54% | - | - | 9.62% | - | 7.78% | 8% | 8.33% |
| EPS 2 | 5,720 | 7,318 | 7,786 | 5,763 | 6,644 | 7,100 | 7,521 | 8,016 |
| Distribution rate | 69.9% | - | - | 174% | - | 98.6% | 95.7% | 93.6% |
| Net sales 1 | 4,003,170 | 4,676,016 | 5,015,395 | 4,884,868 | 5,266,963 | 5,435,000 | 5,690,600 | 5,958,700 |
| EBITDA 1 | 944,647 | 1,157,079 | 1,140,985 | 1,089,971 | 1,105,507 | 1,155,200 | 1,248,900 | 1,335,900 |
| EBIT 1 | 884,537 | 1,112,058 | 1,053,025 | 920,276 | 986,499 | 1,047,900 | 1,137,100 | 1,219,600 |
| Net income 1 | 777,220 | 988,455 | 1,051,490 | 778,920 | 897,576 | 928,400 | 983,400 | 1,048,100 |
| Net Debt 1 | -1,945,982 | - | -1,751,969 | -2,157,944 | -2,153,896 | -1,862,500 | -1,857,800 | -1,850,800 |
| Reference price 2 | 113,000.00 | 84,900.00 | 104,000.00 | 103,900.00 | 102,300.00 | 90,000.00 | 90,000.00 | 90,000.00 |
| Nbr of stocks (in thousands) | 130,746 | 130,746 | 130,746 | 130,746 | 130,746 | 130,746 | - | - |
| Announcement Date | 1/20/22 | 1/19/23 | 1/19/24 | 1/20/25 | 1/20/26 | - | - | - |
1VND in Million2VND
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.69x | 1.82x | 8.59x | 7.77% | 453M | ||
| 32.35x | 11.76x | 23.85x | 0.61% | 1,014B | ||
| 29.73x | 6.61x | 18.52x | 2.01% | 644B | ||
| 33.2x | 7.77x | 16.07x | 2.61% | 464B | ||
| 19.64x | 4.8x | 11.88x | 2.76% | 354B | ||
| 19.71x | 5.15x | 12.77x | 3.12% | 265B | ||
| 20.89x | 4.31x | 12.32x | 2.04% | 253B | ||
| 23.89x | 6.29x | 11.2x | 2.68% | 203B | ||
| 12.12x | 4.42x | 9.24x | 4.14% | 186B | ||
| -44.67x | 6.51x | 25.43x | 2.23% | 183B | ||
| Average | 15.95x | 5.95x | 14.99x | 3% | 356.72B | |
| Weighted average by Cap. | 23.48x | 7.64x | 17.64x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DHG Stock
- Valuation DHG Pharmaceutical
Select your edition
All financial news and data tailored to specific country editions
















